In Vitro Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to Resistance

In vitro selection of remdesivir-resistant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed the emergence of a V166L substitution, located outside of the polymerase active site of the Nsp12 protein, after 9 passages of a single lineage. V166L remained the only Nsp12 substitution...

Descripción completa

Detalles Bibliográficos
Autores principales: Checkmahomed, Liva, Carbonneau, Julie, Du Pont, Venice, Riola, Nicholas C., Perry, Jason K., Li, Jiani, Paré, Bastien, Simpson, Shawn M., Smith, Martin A., Porter, Danielle P., Boivin, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295571/
https://www.ncbi.nlm.nih.gov/pubmed/35708323
http://dx.doi.org/10.1128/aac.00198-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295571/
https://www.ncbi.nlm.nih.gov/pubmed/35708323
http://dx.doi.org/10.1128/aac.00198-22

Ejemplares similares